SynthesisAnnals of the rheumatic diseases2009

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

C Salliot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.